Bill > SF3271

This bill introduces new regulations for 340B Drug Pricing Program entities in Minnesota, focusing on three key areas. First, it defines a new term "nonprofit public interest organization" and allows such organizations to conduct independent audits of 340B covered entities to ensure compliance with program requirements. These audits require full cooperation from 340B entities, who must provide requested data, though the auditing organizations are prohibited from sharing confidential information except through limited legislative reporting. Second, the bill mandates that 340B covered entities must spend at least 25 percent of their net 340B program revenue on charity care, explicitly excluding medical debt write-offs and community service from qualifying expenses. Third, the bill provides enforcement mechanisms, allowing not only the commissioner but also the attorney general to enforce these new requirements. The 340B Drug Pricing Program, established under federal law, is a drug discount program that enables certain healthcare providers to purchase outpatient drugs at reduced prices, and this bill aims to increase transparency and ensure that the financial benefits of the program are directly contributing to charitable healthcare services in Minnesota.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3271&ssn=0&y=2025